Blog Posts by MSHHealthImpact

{Photo by Warren Zelman}Photo by Warren Zelman

We all have an unprecedented opportunity to make universal health coverage a reality.

As a founding partner of the Universal Health Coverage Day (UHC Day) Coalition, Management Sciences for Health is joining forces with the global health community and urging everyone to take action toward universal health coverage on December 12.

UHC Day is founded on the idea that no one should go bankrupt when they get sick, that universal health coverage is a smart investment and an achievable goal everywhere, and that it underpins our collective security and prosperity.

MSH is doing our part to make UHC a reality by:

Following our recent announcement of MSH’s involvement in Hurricane Matthew recovery efforts in Haiti, the Devex global development media platform interviewed MSH Chief Operating Officer Paul Auxila for an article about the rising threat of cholera in Haiti.

Mr. Auxila told Devex that cholera “needs to be a priority and approached differently than the international community did last time,” referring to the 2010 Haiti earthquake response.

He urged organizations to focus on “greatest impact” interventions, such as oral rehydration therapy. “Coordination is a big problem, just like it was after the earthquake,” he added. Interventions need to be more synergistic, working toward a “common goal” and not bypassing the Haitian government, he told Devex.

MSH is partnering with the Haitian government to rebuild the health system in the wake of Hurricane Matthew. At the government’s request, MSH has begun an assessment of the health system to make recommendations for ways to make it stronger. MSH will also assist in deployment of health workers to stem the cholera outbreak.

 Cynthia (left) cares for her grandson, Alime, orphaned to AIDS and living with HIV, in East London, South Africa.

This post is an excerpt from "Medicine Movers," written by Daphne Northrop, and videos by Emily Judem

EAST LONDON, South Africa -- Nine-month-old Alime and his grandmother Cynthia sit at a table piled with pill bottles, cardboard cartons, and syringes. There are 19 items in all. 

The squiggly Alime, who traveled that morning on his grandmother’s back to the hospital, happily munches on a cookie while the pharmacist counsels his grandmother on when he should take each of his medicines and how much to give him. It’s hard to believe such a tiny boy needs so many pills to survive.

Alime has been HIV-positive since birth. His treatment seems to be working. His weight has doubled, and as he smiles and gurgles quietly in Cynthia’s arms, he looks like a healthy toddler. He rarely takes his eyes off his grandmother, and he reaches out to touch her face as she talks.

Medicine Movers: South Africa from Management Sciences for Health on Vimeo.

{Photo credit: Michael Paydos/MSH}Photo credit: Michael Paydos/MSH

This week, Devex and Management Sciences for Health (MSH) are discussing innovations for access to medicines in low- and middle-income countries. Public-private partnerships are key to ensuring innovations help medicines affordably reach the people who need them most.

From communities to global policy: Innovations to access to medicines underway

Devex reporter Andrew Green writes:

In Tanzania in 2002, MSH realized the medicines needed for basic treatment are in the government system, but not available to patients -- either because health facilities ran out of stock or were too far away.

Instead, patients turn to private dispensaries in high numbers. MSH reports that 82 percent of people in sub-Saharan Africa seek health care and medicines from retail drug shops -- even though the people staffing them often have little knowledge or training.

In Tanzania, MSH decided to try to change that, conceptualizing a program in 2002 to set government standards for the accredited drug dispensing outlets, or ADDOs, and upping the knowledge of the people running them. ...

Saving lives and improving health continues long after diagnosing disease or delivering medicines.

(Watch Faith tell her story)

Faith had been ill for months. She was 31 and had two daughters. She didn’t know what was wrong. A friend urged her to get an HIV test; it came back positive.

Faith started on antiretroviral treatment.

But, in 2013, one of her antiretroviral medicines started to work against her, causing misshapen fat deposits to develop on her body.

When she finally mustered the courage to speak up one year later, her doctor knew just what to do and shifted her to a different medicine.

(Medicine Movers: Kenya from Management Sciences for Health on Vimeo)

Faith didn’t know it, but her report to the doctor became part of a nationwide database that tracks adverse drug reactions, and poor quality or expired medicines.

MSH Vice President, Pharmaceuticals & Health Technologies Group, Dr. Douglas Keene, tells Devex how strong governance enables access to medicines.MSH Vice President, Pharmaceuticals & Health Technologies Group, Dr. Douglas Keene, tells Devex how strong governance enables access to medicines.

This week, Management Sciences for Health (MSH) and Devex are talking about how to maximize the impact of access to medicines in low- and middle-income countries. Below are excerpts, descriptions, videos, and links to the conversation. See the full conversation on Access to Medicines.

By strengthening governance and promoting transparency, developing countries can be better equipped to regulate the flow of medicines and support their efficient and effective use. Countries could make much progress by assuring the quality of medicines, but what is really being achieved in practice?

Recent global crises such as Ebola and Zika have revealed the dangers of weak health systems. As countries work to strengthen these systems, Dr. Douglas Keene, vice president of the pharmaceuticals & health technologies group at MSH, advises policymakers to first start by addressing existing regulations and governance.

Aster, a grandmother living with diabetes and TB, invited MSH to accompany her on a visit to the pharmacy at the local hospital in Debre Markos, Ethiopia.

written by Daphne Northrop, video by Emily Judem

How do you ensure that patients get the medicine they need -- at the right dose, when they need it, no matter the circumstances?

Answering that question became the foundation of an enduring partnership between Management Sciences for Health (MSH), USAID, and country governments around the world. Over the past 30 years, as a result of that partnership, countries have made monumental progress in building the systems that move medicines to their final destination: the people who need them.

Medicine Movers, a new microsite by MSH, tells the stories of patients who continue to benefit from these pharmaceutical systems, launched during the peak of the AIDS epidemic.

 {Photo credit: MSH staff}Irene Koek of USAID’s Global Health Bureau gives closing remarks at the health security side event in Geneva.Photo credit: MSH staff

This is the second in a new series on improving the health of the poorest and most vulnerable women, girls, families, and communities by prioritizing prevention and preparing health systems for epidemics (read Part 1). Join the conversation online with hashtag .

World Health Assembly and Beyond: Advancing the Global Health Security Agenda

Outbreaks are inevitable. Epidemics are preventable.

Last month, the No More Epidemics campaign convened a high-level, multi-sectoral panel on the Global Health Security Agenda during the 69th World Health Assembly (WHA69) in Geneva, Switzerland.

{Photos: Warren Zelman (left); Associated Press/Aurelie Marrier d’Unienvil (right)}Photos: Warren Zelman (left); Associated Press/Aurelie Marrier d’Unienvil (right)

This is the first in a new series on improving the health of the poorest and most vulnerable women, girls, families, and communities by prioritizing prevention and preparing health systems for epidemics. Join the conversation online with hashtag .

Prioritizing prevention of regional epidemics and global pandemics

{Photo: Warren Zelman}Photo: Warren Zelman

Last month, MSH President & CEO, Jonathan D. Quick, MD, MPH, urged G7 leaders (Huffington Post Impact) meeting in Ise-Shima, Japan, to prioritize pandemic prevention:

 {Photo credit: Rebecca Weaver/MSH} bit.ly/msh_May2016Photo credit: Rebecca Weaver/MSH

MSH is a worldwide leader in strengthening health care financing systems toward universal health coverage (UHC). Stronger systems. Stronger women and children.

MSH has made tremendous impact on health care financing and UHC in the last two decades.

Performance-based financing

In 1999, MSH pioneered performance-based financing in Haiti, and has continued to adapt and improve upon it since. We contributed to and supported Rwanda to design, implement, and achieve UHC through community-based health insurance and performance-based financing; drastically reduce maternal and child mortality; and meet all of its health Millennium Development Goals.

In Democratic Republic of the Congo, we contributed to drastic reductions in child mortality and some of the greatest results-based financing outcomes in two decades.

Altogether, we've designed and/or implemented performance-based financing interventions in 14 countries across 3 continents (sub-Saharan Africa, Latin America, and South-East Asia).

Pages